Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | OSW | Common Shares | Award | $0 | +12.6K | +58.83% | $0.00 | 34K | Jul 26, 2023 | Direct | F1, F2 |
Id | Content |
---|---|
F1 | The reported transaction reflects a grant of the Issuer's restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one common share, par value $0.0001 per share, of the Issuer (the "Common Shares"). The RSUs vest one year from the grant date. Vested Common Shares will be delivered to the reporting person on the earlier of the 60th day from separation from service and immediately prior to a change in control. |
F2 | Marc Magliacano has entered into a Nominee and Indemnity Agreement, pursuant to which he has agreed that all equity awards granted to him for his service as director of the Issuer are held, from the date of grant, for the benefit of CP7 Nemo Investment, L.P. ("CP7 Nemo Investment"). CP7 Nemo Investment, together with CP7 Caledonia AIV GP, LLP, as the general partner of CP7 Nemo Investment (each of the foregoing, the "L Catterton Entities"), may be deemed to have shared beneficial ownership of the equity awards granted to and held by Mr. Magliacano. Solely for purposes of Section 16 of the Securities and Exchange Act of 1934, the L Catterton Entities may be deemed directors by deputization with respect to the Issuer. |